FrancophonIA/ELRC3.0 huggingface dataset:
English: To encourage patients to contact their MS physician and/or General Practitioner if they experience any of the signs and symptoms discussed in the Patient Education Card; 4.
Croatian: 3. Liječnik mora bolesnike potaknuti da se obrate liječniku koji ih liječi zbog MS-a i/ili liječniku opće prakse u slučaju pojave znakova i simptoma koji se navode u Edukacijskoj kartici za bolesnike
English: In cases of severe haematological reactions, including pancytopenia, AUBAGIO and any concomitant myelosuppressive treatment must be discontinued and a teriflunomide accelerated elimination procedure should be considered.
Croatian: U slučajevima teških hematoloških reakcija, uključujući pancitopeniju, mora se prekinuti primjena lijeka
English: AUBAGIO is for oral use.
Croatian: AUBAGIO se uzima kroz usta.
English: Elevations of liver enzymes have been observed in patients receiving teriflunomide (see section 4.8).
Croatian: U bolesnika koji primaju teriflunomid primijećeno je povećanje razina jetrenih enzima (vidjeti dio 4.8).
English: What AUBAGIO is and what it is used for 2.
Croatian: Što je AUBAGIO i za što se koristi
English: The recommended elimination procedure is cholestyramine 8 g three times a day for 11 days.
Croatian: 8 g triput na dan tijekom 11 dana.
English: Repeated oral administration of teriflunomide to mice, rats and dogs for up to 3, 6, and 12 months, respectively, revealed that the major targets of toxicity were the bone marrow, lymphoid organs, oral cavity/ gastro intestinal tract, reproductive organs, and pancreas.
Croatian: odnosno 12 mjeseci pokazala je da su glavni ciljevi toksičnosti koštana srž, limfoidni organi, usna šupljina/probavni sustav, reproduktivni organi i gušterača.
English: cysts and polyps) There does not appear to be an increased risk of malignancy with teriflunomide in the clinical trial experience.
Croatian: Dobroćudne, zloćudne i nespecificirane novotvorine (uključujući ciste i polipe) Iskustvo iz kliničkih ispitivanja nije pokazalo povećan rizik od malignih bolesti kod primjene teriflunomida.
English: No dosage adjustment is necessary for patients with mild, moderate or severe renal impairment not undergoing dialysis.
Croatian: Oštećenje bubrežne funkcije Nije potrebno prilagođavati dozu u bolesnika s blagim, umjerenim ili teškim oštećenjem bubrežne funkcije koji se ne liječe dijalizom.
English: Therefore no dose adjustment is anticipated in mild, moderate and severe renal-impaired patients.
Croatian: Stoga se ne očekuje prilagođavanje doze u bolesnika s blagim, umjerenim i teškim oštećenjem bubrežne funkcije.
English: Use in males
Croatian: Primjena u muškaraca
English: Risk difference (CI95%) Relapse-free week 108
Croatian: Godišnja stopa relapsa Razlika u riziku (CI95%)
English: Interstitial lung disease (ILD) has been reported with teriflunomide in the postmarketing setting.
Croatian: Respiratorne reakcije Nakon stavljanja teriflunomida u promet prijavljena je intersticijska plućna bolest.
English: AUBAGIO 14 mg film-coated tablets teriflunomide
Croatian: AUBAGIO 14 mg filmom obložene tablete teriflunomid
English: Respiratory, thoracic and mediastinal disorders
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja intersticijska plućna bolest
English: Teriflunomide 14 mg
Croatian: teriflunomide 14 mg placebo teriflunomide 14 mg placebo
English: Switching to or from AUBAGIO
Croatian: Prelazak na AUBAGIO ili prelazak s lijeka AUBAGIO na neki drugi lijek
English: ALT >3 ULN and TBILI >2 ULN
Croatian: ALT >3 GGN i TBILI >2 GGN 5/994 (0,5%)
English: Severe infections including sepsisa
Croatian: uključujući sepsua
English: Therefore, teriflunomide plasma concentrations should be measured before a woman begins to attempt to become pregnant.
Croatian: Stoga se prije pokušaja začeća moraju izmjeriti koncentracije teriflunomida u plazmi.
English: In placebo-controlled studies, frequencies for asthenia were 2.0%, 1.6% and 2.2% in the placebo, teriflunomide 7 mg and teriflunomide 14 mg group, respectively.
Croatian: 1,6% u skupini koja je primala 7 mg teriflunomida i 2,2% u skupini koja je primala 14 mg teriflunomida.
English: ILD and worsening of pre-existing ILD have been reported during treatment with leflunomide, the parent compound of teriflunomide.
Croatian: Intersticijska plućna bolest i pogoršanje postojeće intersticijske plućne bolesti prijavljeni su tijekom liječenja leflunomidom,
English: If the submission of a PSUR and the update of a RMP coincide, they can be submitted at the same time.
Croatian: Ako se podnošenje periodičkog izvješća o neškodljivosti (PSUR) podudara s nadopunama Plana (RMP),
English: Teriflunomide is contraindicated during breast-feeding (see section 4.3).
Croatian: Teriflunomid je kontraindiciran tijekom dojenja (vidjeti dio 4.3).
English: Annualised relapse rate
Croatian: Tablični prikaz nuspojava
English: The following side effects may happen with this medicine.
Croatian: Kod primjene ovoga lijeka primijećene su sljedeće nuspojave.
English: To encourage the patients to read the PIL thoroughly 4.
Croatian: Edukacijska kartica mora potaknuti bolesnike da pažljivo pročitaju Uputu o lijeku
English: - Mild allergic reactions - Feeling anxious - Pins and needles, feeling weak, numb, tingling or pain in the lower back or leg (sciatica); feeling numb, burning, tingling or pain in the hands and fingers (carpal tunnel syndrome)
Croatian: - osjećaj tjeskobe - trnci i bockanje, osjećaj slabosti, utrnulost, trnci ili bol u donjem dijelu leđa ili noge (išijas); osjećaj utrnulosti, žarenje, trnci ili bol u rukama i prstima (sindrom karpalnog tunela) - osjećanje vlastitih otkucaja srca - povišeni krvni tlak - povraćanje, zubobolja, bol u gornjem dijelu trbuha - osip, akne - bol u tetivama, zglobovima, kostima, bol u mišićima (mišićno-koštana bol)
English: - you have respiratory symptoms.
Croatian: - ako imate teške kožne reakcije. - ako imate dišne simptome.
English: Blood and lymphatic system disorders
Croatian: Krvožilni poremećaji hipertenzijab
English: Polska sanofi-aventis Sp. z o.o.
Croatian: Polska sanofi-aventis Sp. z o.o. Tel: +48 22 280 00 00
English: • Of the need for the procedures/tests before and during teriflunomide treatment
Croatian: • informacije o potrebi provođenja pretraga/testova prije i tijekom liječenja teriflunomidom • podsjetnik za bolesnice da obavijeste liječnika ako doje
English: Hazard ratio (CI95%) 3-month Sustained Disability Progression week
Croatian: Tromjesečna trajna progresija onesposobljenosti 108. tjedan
English: Therefore, when warfarin is co-administered with teriflunomide, close INR follow-up and monitoring is recommended.
Croatian: Stoga se preporučuje pomna kontrola i praćenje INR-a kada se varfarin primjenjuje istodobno s teriflunomidom.
English: Posology
Croatian: Medijan
English: There was an increase in mean rosuvastatin Cmax and AUC (2.65- and 2.51-fold, respectively), following repeated doses of teriflunomide.
Croatian: Nakon ponovljenih doza teriflunomida srednja vrijednost Cmax rosuvastatina povećala se 2,65 puta, a AUC 2,51 puta.
English: Hazard ratio (CI95%) 6-month Sustained Disability Progression week
Croatian: Šestomjesečna trajna progresija onesposobljenosti 108. tjedan
English: Description of selected adverse reactions
Croatian: Opis odabranih nuspojava Alopecija
English: Interference with determination of ionised calcium levels
Croatian: - cimetidin za smanjenje želučane kiseline
English: Mild and moderate hepatic impairment had no impact on the pharmacokinetic of teriflunomide.
Croatian: Blago i umjereno oštećenje jetrene funkcije nije imalo učinka na farmakokinetiku teriflunomida pa se ne očekuje prilagođavanje doze u bolesnika s blagim i umjerenim oštećenjem jetrene funkcije.
English: • Alanine aminotransferase/serum glutamic pyruvic transaminase (ALT/SGPT) o Liver enzymes should be assessed every two weeks during the first 6 months of treatment, and every 8 weeks thereafter or as indicated by clinical signs and symptoms such as unexplained nausea, vomiting, abdominal pain, fatigue, anorexia, or jaundice and/or dark urine.
Croatian: tjedana nakon toga ili po potrebi u skladu s kliničkim znakovima i simptomima kao što su neobjašnjiva mučnina, povraćanje, bol u abdomenu, umor, anoreksija ili žutica i/ili tamna mokraća.
English: Change relative to placebo Mean Number of Gdenhancing lesions at week
Croatian: Promjena u odnosu na placebo
English: Interstitial lung disease
Croatian: gljivična infekcija stopala
English: • Risk of infections/serious infections o To discuss the need to contact the doctor in the event of signs/symptoms of infection, or if the patient takes other medicines that affect the immune system 2.
Croatian: • rizik od hematoloških učinaka o liječnik mora bolesnika upozoriti na potrebu za izradom kompletne krvne slike prije liječenja i periodički za vrijeme njegova trajanja, na temelju znakova i simptoma • rizik od infekcija/ozbiljnih infekcija o liječnik mora s bolesnikom razgovarati o potrebi da se obrati liječniku u slučaju pojave znakova/simptoma infekcije ili ako uzima druge lijekove koji utječu na imunološki sustav 2. Podsjetnik da bolesnicima uruči Edukacijsku karticu za bolesnike, u koju mora unijeti svoje kontaktne podatke, te da im po potrebi uruči zamjensku Edukacijsku karticu za bolesnike
English: Mild thrombocytopen ia (platelets <100G/l)
Croatian: Poremećaji krvi i limfnog sustava neutropenijab, anemija blaga trombocitop enija (trombociti <100 G/l)
English: Hepatic impairment
Croatian: - posttraumatska bol
English: Reproductive system and breast disorders
Croatian: Poremećaji reproduktiv nog sustava i dojki menoragija
English: Skin and subcutaneous tissue disorders
Croatian: Poremećaji kože i potkožnog tkiva alopecija osip, akne poremećaji noktiju teške kožne reakcijea psorijaza
English: • Risk of hypertension o to check for a history of hypertension and that blood pressure should be appropriately managed during treatment o the need for blood pressure checks before treatment and periodically during treatment,
Croatian: razmotriti primjenu postupka ubrzane eliminacije i o tome razgovarati s bolesnicom potaknuti bolesnicu da se prijavi u registar trudnoće (u onim zemljama gdje takav registar postoji) • rizik od hipertenzije o liječnik mora provjeriti ima li bolesnik u anamnezi hipertenziju te se mora pobrinuti da se krvni tlak liječi na odgovarajući način tijekom liječenja o liječnik mora bolesnika upozoriti na potrebu za kontrolama krvnoga tlaka prije liječenja i periodički za vrijeme njegova trajanja
English: SANOFI BULGARIA EOOD Tел: +359 2 970 53 00
Croatian: Tел: +359 2 9705300
English: Nervous system disorders
Croatian: Poremećaji probavnog sustava proljev,
English: Nail disorders
Croatian: Prijavljivanje nuspojava
English: Neutropeniab, Anaemia
Croatian: Psihijatrijski poremećaji anksioznost
English: Oral herpes, Tooth infection, Laryngitis, Tinea pedis
Croatian: Poremećaji mišićno koštanog sustava i vezivnog tkiva mišićno-koštana bol, mijalgija, artralgija
English: Common (may affect up to 1 in 10 people) - Influenza, upper respiratory tract infection, urinary tract infection, bronchitis, sinusitis, sore throat and discomfort when swallowing, cystitis, gastroenteritis viral, oral herpes, tooth infection, laryngitis, fungal infection of the foot - Laboratory values: a decrease in the number of red blood cells (anaemia), changes in liver and white blood cell test results (see section 2), as well as elevations in a muscle enzyme (creatine phosphokinase) have been observed.
Croatian: - laboratorijske vrijednosti: primijećeno je smanjenje broja crvenih krvnih stanica (anemija), promjene u rezultatima jetrenih proba i pretraga bijelih krvnih stanica (vidjeti dio 2), kao i povećanja vrijednosti mišićnog enzima (kreatin-fosfokinaze).
English: Gammaglutamyltransfer ase (GGT) increaseb, Aspartate aminotransferas
Croatian: Poremećaji jetre i žuči povišene vrijednosti alanin aminotrans feraze (ALT)b povišene vrijednosti gamaglutamiltransfera ze (GGT)b, povišene vrijednosti aspartat aminotransferaze b akutni hepatitis
English: What you need to know before you take AUBAGIO Do not take AUBAGIO:
Croatian: Nemojte uzimati AUBAGIO:
English: Accelerated Elimination Procedure: Cholestyramine and activated charcoal
Croatian: Preporučeni postupak eliminacije je primjena kolestiramina u dozi od
English: - you take leflunomide with AUBAGIO.
Croatian: - ako uzimate leflunomid s lijekom AUBAGIO. - ako prelazite na AUBAGIO ili s lijeka AUBAGIO na neki drugi lijek. - ako ne podnosite laktozu.
English: The warnings are appropriate.
Croatian: Upozorenja su odgovarajuća.
English: For the pour-on product 24 concerned member states (CMS) are involved: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia and Spain.
Croatian: U odobravanje poliva uključene su 24 države članice: Austrija, Belgija, Bugarska, Cipar, Češka Republika, Danska, Estonija, Francuska, Njemačka, Grčka, Mađarska, Island, Irska, Italija, Latvija, Litva, Luksemburg, Nizozemska, Poljska, Portugal, Rumunjska, Slovačka, Slovenija i Španjolska.
English: The efficacy of Deltanil has been demonstrated according to current rules during the decentralised procedure.
Croatian: Djelotvornost Deltanila dokazana je u skladu s trenutnim pravilima tijekom decentraliziranog postupka.
English: The active substance is well known and is included in veterinary medicinal products currently authorised in the EU.
Croatian: Djelatna tvar je dobro poznata i uključena u trenutno odobrene veterinarsko-medicinske proizvode u EU.
English: Direct therapeutic benefit
Croatian: Izravna terapijska dobrobit
English: The reference member state (RMS) is the United Kingdom for both products.
Croatian: Referentna država članica za oba proizvoda (RMS) je Ujedinjeno Kraljevstvo.
English: The benefit-risk for the products can be considered to be positive.
Croatian: Omjer dobrobiti i rizika za proizvode može se smatrati pozitivnim.
English: The use of the products was not expected to pose a risk for soil, groundwater and surface water.
Croatian: Ne očekuje se da će upotreba proizvoda predstavljati rizik za tlo, podzemne i površinske vode.
English: Considering the data submitted, the Committee concluded as follows on issues raised in the notification received from Germany and the Netherlands.
Croatian: Uzimajući u obzir podnesene podatke, Povjerenstvo je zaključilo sljedeće o pitanjima koja su postavila Njemačka i Nizozemska u svojoj notifikaciji.
English: Efficacy was not assessed in this referral procedure.
Croatian: Djelotvornost nije procijenjena u ovom postupku procjene.
English: Deltamethrin was shown to have a half-life in soil of 72 days based on acceptable published data.
Croatian: Dokazano je da deltametrin ima poluživot u tlu od 72 dana na temelju, prihvatljivih objavljenih podataka.
English: For the spot-on product Belgium, France, Germany and the Netherlands are involved as CMS.
Croatian: Za proizvode na nakapavanje Belgija, Francuska, Njemačka i Nizozemska uključene su kao države članice.
English: No additional studies were carried out in order to further refine the risk as guidance in this area is not currently available.
Croatian: Nisu provedena dodatna ispitivanja kako bi se pobliže odredio rizik jer trenutno nema dostupnih smjernica za ovo područje.
English: The ERA was complete in terms of data requirements and quality of data.
Croatian: ERA je dovršena u smislu zahtjeva za podacima te kvalitetom podataka.
English: The RQ values for surface water were <1 for all target animal types.
Croatian: RQ vrijednosti za površinske vode bile su manje od 1 za sve ciljne tipove životinja.
English: As the PECgroundwater was below 0.1 µg/l no further assessment for the water compartment was required.
Croatian: S obzirom da je PECu podzemnim vodama bila ispod 0,1 µg/l nije bila potrebna daljnja procjena odjeljka vode.
English: Animal species
Croatian: Ciljane vrste životinja
English: New acute OECD studies were carried out on aquatic organisms followed by an OECD chronic study with daphnia.
Croatian: Nova akutna OECD ispitivanja provedena su na vodenim organizmima nakon kroničnog ispitivanja OECD s dafnijom.
English: 1 VICH GL6: Guideline on Environmental Impact Assessment (EIAS) for Veterinary Medicinal Products - Phase I
Croatian: 1 VICH GL6: Smjernice o procjeni utjecaja na okoliš (EIAS) za veterinarsko-medicinske proizvode - Faza I
English: Data from an acceptable study gave a bioconcentration factor of 510 l/kg which is below the value of 2000 l/kg which would indicate a potential to bioaccumulate.
Croatian: Podaci iz prihvatljivog ispitivanja dali su faktor biokoncentracije od 510 l/kg što je ispod vrijednosti od 2000 l/kg koja bi ukazivala na potencijal bioakumulacije.
English: Furthermore, appropriate risk mitigation measures (RMMs) were considered missing in the product information as a consequence of the identified unacceptable risk to aquatic organisms.
Croatian: Nadalje, odgovarajuće mjere za smanjenje rizika smatrane su manjkavim u informacijama o proizvodu kao posljedica identificiranog neprihvatljivog rizika za vodene organizme.
English: It provided all the information required to be able to make a conclusion on the environmental risk presented by the use of the products.
Croatian: Dala je sve informacije potrebne za donošenje zaključka o riziku za okoliš koji predstavlja upotreba ovih proizvoda.
English: A new study was carried out on earthworms according to the recommended OECD guideline and a predicted no effect concentration (PNEC) was derived using the accepted assessment factor (10).
Croatian: Provedeno je novo ispitivanje na kišnim glistama u skladu s preporučenim smjernicama OECD te je izvedena predviđena koncentracija bez učinka (PNEC) upotrebom prihvaćenog faktora procjene (10).
English: However, it was considered that information on the possible accumulation of deltamethrin in sediments should be communicated to the user in the product information.
Croatian: Međutim, smatralo se da je potrebno prenijeti korisnicima informacije o mogućoj akumulaciji deltametrina u sedimentima putem informacija o proizvodu.
English: No degradation rate for deltamethrin in sediment was required in order to complete the ERA, but some information in the published literature suggests that in some sediments degradation occurs with a half-life in soil of about 10 days (Åkerblom et al. 2008)4.
Croatian: Nije bilo potrebno određivati stupanj degradacije deltametrina u sedimentu kako bi se dovršila ERA ali neke informacije u objavljenoj literaturi ukazuju da se u nekim sedimentima degradacija događa s poluživotom u zemlji od otprilike 10 dana (Åkerblom et al.
English: Having considered all the overall submitted data in writing the CVMP concluded that the ERA for Deltanil Pour-On and Spot-on products shows that the products are not expected to pose a risk for the environment when used as recommended in the product information including the recommended RMMs.
Croatian: Uzimajući u obzir sve predane pismene podatke, CVMP je zaključio da ERA za Deltanil otopine za polijevanje i nakapavanje pokazuje da se ne očekuje da će proizvodi predstavljati rizik za okoliš kad se koriste na način preporučen u informacijama o proizvodu uključujući preporučene mjere smanjenja rizika.
English: As deltamethrin has a n-octanol/water partition coefficient (KOW, expressed as logKOW) of >5.1, its bioaccumulation potential, potential for being considered a persistent, bioaccumulative and toxic (PBT) compound and secondary poisoning were addressed as required by the VICH and CVMP guidelines.
Croatian: S obzirom da deltametrin ima koeficijent particije n-oktanol/voda (KOW, izražen kao logKOW) od > 5,1, njegov bioakumulacijski potencijal, potencijal za uvrštavanje među trajne, bioakumulativne i toksične (PBT) tvari i sekundarno trovanje bili su obrađeni u skladu sa smjernicama VICH i CVMP.
English: Quality, target animal safety, user safety and residues were not assessed in this referral procedure, as no concern was notified by the reference Member State.
Croatian: U ovom postupku procjene nisu procjenjivani kvaliteta, sigurnost ciljnih životinja, sigurnost korisnika i rezidue jer referentna država članica nije izrazila nikakvu zabrinutost oko navedenih stavki.
English: Acceptable data on the acute toxicity of deltamethrin to dung fly larvae and adult beetles were provided which indicated that RQ values for dung insects were in the order of 90 - 10 000.
Croatian: Podneseni su prihvatljivi podaci o akutnoj toksičnosti deltametrina za larve izmetne muhe i odraslih buba što je ukazivalo da su vrijednosti RQ za insekte koji se hrane otpadom bile reda veličine od 90 - 10 000.
English: The adsorption/desorption of deltamethrin was determined by the HPLC method which showed that deltamethrin was expected to be non-mobile in soil.
Croatian: Adsorpcija/desorpcija deltametrina određena je metodom HPLC koja je pokazala da se očekuje da deltametrin neće biti mobilan u tlu.
English: Using these data PNECs were derived using the appropriate assessment factors.
Croatian: Vrijednosti ONEC izvedene su upotrebom ovih podataka te odgovorajućih faktora procjene.
English: List of the names, pharmaceutical forms, strengths of the veterinary medicinal products, animal species, route of administration, applicant in the Member States
Croatian: Popis imena, farmaceutskog oblika, jačine veterinarsko medicinskog proizvoda, ciljanih vrsta životinja, načina i puteva primjene, podnositelja zahtijeva u zemljama članicama EU.
English: An ERA in accordance with VICH and CVMP guidelines was provided which contained a mixture of published and bespoke studies from the applicant and addressed all aspects of environmental risk.
Croatian: Osigurana je ERA u skladu s VICH i CVMP smjernicama koja je sadržavala mješavinu objavljenih i naviještenih ispitivanja od strane podnositelja zahtjeva i obratila pozornost na sve aspekte rizika za okoliš.
English: As a result of this referral it was considered that due to the high adsorption coefficient (KOC) of deltamethrin the following environmental information should also be added to the previously agreed warning sentence in the SPC (section 5 Environmental Properties) and the package leaflet (section 15 Environmental Properties) "...and may accumulate in sediment".
Croatian: Kao rezultat ove procjene smatralo sa da zbog velikog koeficijenta adsorpcije (KOC) deltametrina sljedeće informacije o okolišu treba također dodati prethodno dogovorenoj rečenici upozorenja u SPC-u (poglavlje 5 Svojstva okoliša) i u Uputi o VMP (Poglavlje 15 Svojstva okoliša) "...i može se akumulirati u sedimentu".
English: In order to address the concerns raised by the referral, the applicant provided an environmental risk assessment (ERA) in accordance with VICH guidelines GL61 and GL382 and in accordance with the CVMP guideline in support of VICH guidelines GL6 and GL38 (EMEA/CVMP/ERA/418282/2005)3.
Croatian: Kako bi se obratio pozornost na zabrinutost koja je iskazana tijekom procjene, podnositelj zahtjeva osigurao je procjenu rizika za okoliš (ERA) u skladu sa smjernicama VICH GL61 i GL382 te u skladu s CVMP smjernicama koje podržavaju VICH smjernice GL6 i GL38 (EMEA/CVMP/ERA/418282/2005)3.
English: Scientific justifications were provided for the cases of deviations from guidelines and a number of peer reviewed publications were submitted.
Croatian: Podnesena su znanstvena opravdanja predviđena za slučajeve odstupanja od smjernica i određenih broj recenzija.
English: A screening for PBT properties as required by the CVMP guidelines indicated that deltamethrin did not fulfil the criteria for either 'P' or 'B' although it is considered to be 'T'.
Croatian: Probir na PBT svojstva potreban prema smjernicama CVMP ukazivao je deltametrin nije ispunio kriterije bilo za "P" ili "B" iako je smatran kategorijom "T".
English: Risk Assessment
Croatian: Procjena rizika
English: The high soil adsorption coefficient (KOC, expressed as logKOC) of >4.2 suggests that any deltamethrin which enters the aquatic environment will move to the sediment.
Croatian: Visoki koeficijent adsorpcije u tlu (KOC, izražen kao logKOC) od >4,2 ukazuje da će bilo koja količina deltametrina koja ulazi u vodeni okoliš izaći iz njega kao sediment.